APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Viscometer

Blood Viscometer is an instrument used to measure the viscosity of a fluid. For liquids with viscosities which vary with flow conditions, an instrument called a rheometer is used. Viscometers only measure under one flow condition.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Blood Viscometer is an instrument used to measure the viscosity of a fluid. For liquids with viscosities which vary with flow conditions, an instrument called a rheometer is used. Viscometers only measure under one flow condition.

Selected research

Market Outlook & Growth Opportunities

Global Blood Viscometer Market Outlook and Growth Opportunities 2026

1 January 2026193 pages

Choose your research edition.

Industry ResearchBlood Viscometer Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Viscometer Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Blood Viscometer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Viscometer Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Viscometer Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Blood Viscometer is an instrument used to measure the viscosity of a fluid. For liquids with viscosities which vary with flow conditions, an instrument called a rheometer is used. Viscometers only measure under one flow condition.

Market competition is intense. Anton Paar, Thermo Fisher Scientific, Brookfield, RheoSense and Health Onvector, etc. are the leaders of the industry, with about 64% market shares.

North America is the largest consumption place, with a consumption market share nearly 38%. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.

Read the full market overview

This report provides an overview of the global Blood Viscometer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Viscometer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Viscometer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Viscometer market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Viscometer Segment by Company

Anton Paar

Thermo Fisher Scientific

Brookfield

RheoSense

Health Onvector

​BioFluid Technology

LAUDA

LAMY RHEOLOGY

Benson Viscometers

HRD

Blood Viscometer Segment by Type

Rotational Viscometer

Capillary Viscometer

Blood Viscometer Segment by Application

Hospital

Clinic

Laboratory

Blood Viscometer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Viscometer status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Blood Viscometer market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Viscometer significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Viscometer competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Viscometer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Viscometer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Viscometer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Viscometer market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Viscometer industry.

Chapter 3: Detailed analysis of Blood Viscometer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Blood Viscometer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Blood Viscometer in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Viscometer Industry Trends Table 2. Blood Viscometer Industry Drivers Table 3. Blood Viscometer Industry Opportunities and Challenges Table 4. Blood Viscometer Industry Restraints Table 5. Global Blood Viscometer Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Viscometer Revenue Share by Company (2021-2026) Table 7. Global Blood Viscometer Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Blood Viscometer Sales Volume Share by Company (2021-2026) Table 9. Global Blood Viscometer Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Blood Viscometer Company Ranking, (2024-2026) & (USD Million) Table 11. Global Blood Viscometer Key Company Manufacturing Base & Headquarters Table 12. Global Blood Viscometer Company, Product Type & Application Table 13. Global Blood Viscometer Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood Viscometer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rotational Viscometer Table 18. Significant Companies of Capillary Viscometer Table 19. Global Blood Viscometer Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Blood Viscometer Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Blood Viscometer Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Blood Viscometer Sales Volume Share by Type (2021-2026) Table 23. Global Blood Viscometer Sales Volume Share by Type (2027-2032) Table 24. Global Blood Viscometer Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Blood Viscometer Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Blood Viscometer Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Blood Viscometer Sales Value Share by Type (2021-2026) Table 28. Global Blood Viscometer Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Laboratory Table 32. Global Blood Viscometer Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Blood Viscometer Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Blood Viscometer Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Blood Viscometer Sales Volume Share by Application (2021-2026) Table 36. Global Blood Viscometer Sales Volume Share by Application (2027-2032) Table 37. Global Blood Viscometer Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Blood Viscometer Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Blood Viscometer Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Blood Viscometer Sales Value Share by Application (2021-2026) Table 41. Global Blood Viscometer Sales Value Share by Application (2027-2032) Table 42. Global Blood Viscometer Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Blood Viscometer Sales by Region (2021-2026) & (K Units) Table 44. Global Blood Viscometer Sales Market Share by Region (2021-2026) Table 45. Global Blood Viscometer Sales by Region (2027-2032) & (K Units) Table 46. Global Blood Viscometer Sales Market Share by Region (2027-2032) Table 47. Global Blood Viscometer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Blood Viscometer Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Blood Viscometer Sales Value Share by Region (2021-2026) Table 50. Global Blood Viscometer Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Blood Viscometer Sales Value Share by Region (2027-2032) Table 52. Global Blood Viscometer Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Blood Viscometer Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Blood Viscometer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Blood Viscometer Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Blood Viscometer Sales by Country (2021-2026) & (K Units) Table 57. Global Blood Viscometer Sales Market Share by Country (2021-2026) Table 58. Global Blood Viscometer Sales by Country (2027-2032) & (K Units) Table 59. Global Blood Viscometer Sales Market Share by Country (2027-2032) Table 60. Global Blood Viscometer Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Blood Viscometer Sales Value Market Share by Country (2021-2026) Table 62. Global Blood Viscometer Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Blood Viscometer Sales Value Market Share by Country (2027-2032) Table 64. Anton Paar Company Information Table 65. Anton Paar Business Overview Table 66. Anton Paar Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Anton Paar Blood Viscometer Product Portfolio Table 68. Anton Paar Recent Development Table 69. Thermo Fisher Scientific Company Information Table 70. Thermo Fisher Scientific Business Overview Table 71. Thermo Fisher Scientific Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Thermo Fisher Scientific Blood Viscometer Product Portfolio Table 73. Thermo Fisher Scientific Recent Development Table 74. Brookfield Company Information Table 75. Brookfield Business Overview Table 76. Brookfield Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Brookfield Blood Viscometer Product Portfolio Table 78. Brookfield Recent Development Table 79. RheoSense Company Information Table 80. RheoSense Business Overview Table 81. RheoSense Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. RheoSense Blood Viscometer Product Portfolio Table 83. RheoSense Recent Development Table 84. Health Onvector Company Information Table 85. Health Onvector Business Overview Table 86. Health Onvector Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Health Onvector Blood Viscometer Product Portfolio Table 88. Health Onvector Recent Development Table 89. ​BioFluid Technology Company Information Table 90. ​BioFluid Technology Business Overview Table 91. ​BioFluid Technology Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. ​BioFluid Technology Blood Viscometer Product Portfolio Table 93. ​BioFluid Technology Recent Development Table 94. LAUDA Company Information Table 95. LAUDA Business Overview Table 96. LAUDA Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. LAUDA Blood Viscometer Product Portfolio Table 98. LAUDA Recent Development Table 99. LAMY RHEOLOGY Company Information Table 100. LAMY RHEOLOGY Business Overview Table 101. LAMY RHEOLOGY Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. LAMY RHEOLOGY Blood Viscometer Product Portfolio Table 103. LAMY RHEOLOGY Recent Development Table 104. Benson Viscometers Company Information Table 105. Benson Viscometers Business Overview Table 106. Benson Viscometers Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Benson Viscometers Blood Viscometer Product Portfolio Table 108. Benson Viscometers Recent Development Table 109. HRD Company Information Table 110. HRD Business Overview Table 111. HRD Blood Viscometer Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. HRD Blood Viscometer Product Portfolio Table 113. HRD Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Blood Viscometer Distributors List Table 117. Blood Viscometer Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Blood Viscometer Product Image Figure 2. Global Blood Viscometer Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Viscometer Sales Value (2021-2032) & (US$ Million) Figure 4. Global Blood Viscometer Sales (2021-2032) & (K Units) Figure 5. Global Blood Viscometer Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Blood Viscometer Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rotational Viscometer Image Figure 10. Capillary Viscometer Image Figure 11. Global Blood Viscometer Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Blood Viscometer Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Blood Viscometer Sales Volume Share by Type (2021-2032) Figure 14. Global Blood Viscometer Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Blood Viscometer Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Blood Viscometer Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Laboratory Image Figure 20. Global Blood Viscometer Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Blood Viscometer Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Blood Viscometer Sales Volume Share by Application (2021-2032) Figure 23. Global Blood Viscometer Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Blood Viscometer Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Blood Viscometer Sales Value Share by Application (2021-2032) Figure 26. Global Blood Viscometer Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Blood Viscometer Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Blood Viscometer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Blood Viscometer Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Blood Viscometer Sales Value (2021-2032) & (US$ Million) Figure 31. North America Blood Viscometer Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Blood Viscometer Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Blood Viscometer Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Blood Viscometer Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Blood Viscometer Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Blood Viscometer Sales Value (2021-2032) & (US$ Million) Figure 37. South America Blood Viscometer Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Blood Viscometer Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Blood Viscometer Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Blood Viscometer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Blood Viscometer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Blood Viscometer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Blood Viscometer Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Blood Viscometer Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Rotational Viscometer
  • Capillary Viscometer
Applications
  • Hospital
  • Clinic
  • Laboratory
Companies covered
  • Anton Paar
  • Thermo Fisher Scientific
  • Brookfield
  • RheoSense
  • Health Onvector
  • ​BioFluid Technology
  • LAUDA
  • LAMY RHEOLOGY
  • Benson Viscometers
  • HRD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood Viscometer Sales Value (2021-2032)
  4. 1.2.2 Global Blood Viscometer Sales Volume (2021-2032)
  5. 1.2.3 Global Blood Viscometer Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Blood Viscometer Market Dynamics
  1. 2.1 Blood Viscometer Industry Trends
  2. 2.2 Blood Viscometer Industry Drivers
  3. 2.3 Blood Viscometer Industry Opportunities and Challenges
  4. 2.4 Blood Viscometer Industry Restraints
3 Blood Viscometer Market by Company
  1. 3.1 Global Blood Viscometer Company Revenue Ranking in 2025
  2. 3.2 Global Blood Viscometer Revenue by Company (2021-2026)
  3. 3.3 Global Blood Viscometer Sales Volume by Company (2021-2026)
  4. 3.4 Global Blood Viscometer Average Price by Company (2021-2026)
  5. 3.5 Global Blood Viscometer Company Ranking (2024-2026)
  6. 3.6 Global Blood Viscometer Company Manufacturing Base and Headquarters
  7. 3.7 Global Blood Viscometer Company Product Type and Application
  8. 3.8 Global Blood Viscometer Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Blood Viscometer Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Blood Viscometer Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Blood Viscometer Market by Type
  1. 4.1 Blood Viscometer Type Introduction
  2. 4.1.1 Rotational Viscometer
  3. 4.1.2 Capillary Viscometer
  4. 4.2 Global Blood Viscometer Sales Volume by Type
  5. 4.2.1 Global Blood Viscometer Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Blood Viscometer Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Blood Viscometer Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Blood Viscometer Sales Value by Type
  9. 4.3.1 Global Blood Viscometer Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Blood Viscometer Sales Value by Type (2021-2032)
  11. 4.3.3 Global Blood Viscometer Sales Value Share by Type (2021-2032)
5 Blood Viscometer Market by Application
  1. 5.1 Blood Viscometer Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Laboratory
  5. 5.2 Global Blood Viscometer Sales Volume by Application
  6. 5.2.1 Global Blood Viscometer Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Viscometer Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Blood Viscometer Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Blood Viscometer Sales Value by Application
  10. 5.3.1 Global Blood Viscometer Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Blood Viscometer Sales Value by Application (2021-2032)
  12. 5.3.3 Global Blood Viscometer Sales Value Share by Application (2021-2032)
6 Blood Viscometer Regional Sales and Value Analysis
  1. 6.1 Global Blood Viscometer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Viscometer Sales by Region (2021-2032)
  3. 6.2.1 Global Blood Viscometer Sales by Region: 2021-2026
  4. 6.2.2 Global Blood Viscometer Sales by Region (2027-2032)
  5. 6.3 Global Blood Viscometer Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Blood Viscometer Sales Value by Region (2021-2032)
  7. 6.4.1 Global Blood Viscometer Sales Value by Region: 2021-2026
  8. 6.4.2 Global Blood Viscometer Sales Value by Region (2027-2032)
  9. 6.5 Global Blood Viscometer Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Blood Viscometer Sales Value (2021-2032)
  12. 6.6.2 North America Blood Viscometer Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Blood Viscometer Sales Value (2021-2032)
  15. 6.7.2 Europe Blood Viscometer Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Blood Viscometer Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Blood Viscometer Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Blood Viscometer Sales Value (2021-2032)
  21. 6.9.2 South America Blood Viscometer Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Blood Viscometer Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Blood Viscometer Sales Value Share by Country, 2025 VS 2032
7 Blood Viscometer Country-level Sales and Value Analysis
  1. 7.1 Global Blood Viscometer Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Viscometer Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Blood Viscometer Sales by Country (2021-2032)
  4. 7.3.1 Global Blood Viscometer Sales by Country (2021-2026)
  5. 7.3.2 Global Blood Viscometer Sales by Country (2027-2032)
  6. 7.4 Global Blood Viscometer Sales Value by Country (2021-2032)
  7. 7.4.1 Global Blood Viscometer Sales Value by Country (2021-2026)
  8. 7.4.2 Global Blood Viscometer Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Blood Viscometer Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Blood Viscometer Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Blood Viscometer Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Blood Viscometer Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Blood Viscometer Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Blood Viscometer Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Blood Viscometer Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Blood Viscometer Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Blood Viscometer Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Blood Viscometer Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Blood Viscometer Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Blood Viscometer Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Blood Viscometer Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Blood Viscometer Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Blood Viscometer Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Blood Viscometer Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Blood Viscometer Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Blood Viscometer Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Blood Viscometer Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Blood Viscometer Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Blood Viscometer Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Blood Viscometer Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Blood Viscometer Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Blood Viscometer Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Blood Viscometer Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Blood Viscometer Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Blood Viscometer Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Blood Viscometer Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Blood Viscometer Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Blood Viscometer Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Blood Viscometer Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Anton Paar
  2. 8.1.1 Anton Paar Company Information
  3. 8.1.2 Anton Paar Business Overview
  4. 8.1.3 Anton Paar Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Anton Paar Blood Viscometer Product Portfolio
  6. 8.1.5 Anton Paar Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Blood Viscometer Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Brookfield
  14. 8.3.1 Brookfield Company Information
  15. 8.3.2 Brookfield Business Overview
  16. 8.3.3 Brookfield Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Brookfield Blood Viscometer Product Portfolio
  18. 8.3.5 Brookfield Recent Developments
  19. 8.4 RheoSense
  20. 8.4.1 RheoSense Company Information
  21. 8.4.2 RheoSense Business Overview
  22. 8.4.3 RheoSense Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 RheoSense Blood Viscometer Product Portfolio
  24. 8.4.5 RheoSense Recent Developments
  25. 8.5 Health Onvector
  26. 8.5.1 Health Onvector Company Information
  27. 8.5.2 Health Onvector Business Overview
  28. 8.5.3 Health Onvector Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Health Onvector Blood Viscometer Product Portfolio
  30. 8.5.5 Health Onvector Recent Developments
  31. 8.6 ​BioFluid Technology
  32. 8.6.1 ​BioFluid Technology Company Information
  33. 8.6.2 ​BioFluid Technology Business Overview
  34. 8.6.3 ​BioFluid Technology Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 ​BioFluid Technology Blood Viscometer Product Portfolio
  36. 8.6.5 ​BioFluid Technology Recent Developments
  37. 8.7 LAUDA
  38. 8.7.1 LAUDA Company Information
  39. 8.7.2 LAUDA Business Overview
  40. 8.7.3 LAUDA Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LAUDA Blood Viscometer Product Portfolio
  42. 8.7.5 LAUDA Recent Developments
  43. 8.8 LAMY RHEOLOGY
  44. 8.8.1 LAMY RHEOLOGY Company Information
  45. 8.8.2 LAMY RHEOLOGY Business Overview
  46. 8.8.3 LAMY RHEOLOGY Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LAMY RHEOLOGY Blood Viscometer Product Portfolio
  48. 8.8.5 LAMY RHEOLOGY Recent Developments
  49. 8.9 Benson Viscometers
  50. 8.9.1 Benson Viscometers Company Information
  51. 8.9.2 Benson Viscometers Business Overview
  52. 8.9.3 Benson Viscometers Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Benson Viscometers Blood Viscometer Product Portfolio
  54. 8.9.5 Benson Viscometers Recent Developments
  55. 8.10 HRD
  56. 8.10.1 HRD Company Information
  57. 8.10.2 HRD Business Overview
  58. 8.10.3 HRD Blood Viscometer Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 HRD Blood Viscometer Product Portfolio
  60. 8.10.5 HRD Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood Viscometer Value Chain Analysis
  2. 9.1.1 Blood Viscometer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood Viscometer Sales Mode & Process
  6. 9.2 Blood Viscometer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood Viscometer Distributors
  9. 9.2.3 Blood Viscometer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst